Pimavanserin tartrate

Pimavanserin (ACP-103) is a highly effective and selective 5-HT2A inverse agonist with a pIC50 of 8.73, used to treat Parkinson's disease-related mental disorders.

Description : Pimavanserin is a potent and selective serotonin 5-HT2A inverse agonist. It has been used as an atypical antipsychotic in the treatment of psychosis associated with Parkinson's disease.

• Molecular Weight :1005.2

Molecular Formula : C50H68F2N6O4·C4H6O6 Canonical SMILES : CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.C(C(C(=O)O)O)(C(=O)O)O InChI : ACP-103

Shandong Ench Chemical Co.,Ltd

Unii-na83F1sjsr

Leap Chem Co., Ltd +2 additional providers that we know from the past

Pimavanserin Dihydroxysuccinate(2:1)

+1 additional providers that we know from the past

Acp-103; bvf-048;nuplazid;pimavanserin tartrate

+1 additional providers that we know from the past

(2R,3R)-2,3-Dihydroxybutanedioic acid;1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea

+1 additional providers that we know from the past